The benefits, costs and feasibility of a low incidence COVID-19 strategy

In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have range...

Descripción completa

Detalles Bibliográficos
Autores principales: Czypionka, Thomas, Iftekhar, Emil N., Prainsack, Barbara, Priesemann, Viola, Bauer, Simon, Calero Valdez, André, Cuschieri, Sarah, Glaab, Enrico, Grill, Eva, Krutzinna, Jenny, Lionis, Christos, Machado, Helena, Martins, Carlos, Pavlakis, George N., Perc, Matjaž, Petelos, Elena, Pickersgill, Martyn, Skupin, Alexander, Schernhammer, Eva, Szczurek, Ewa, Tsiodras, Sotirios, Willeit, Peter, Wilmes, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720492/
https://www.ncbi.nlm.nih.gov/pubmed/35005678
http://dx.doi.org/10.1016/j.lanepe.2021.100294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720492/
https://www.ncbi.nlm.nih.gov/pubmed/35005678
http://dx.doi.org/10.1016/j.lanepe.2021.100294

Ejemplares similares